“Comparison of the Effectiveness and Safety of Allopurinol and Febuxostat Use in CKD Patients with Hyperuricemia: A Systematic Review” (2026) JURNAL FARMASIMED (JFM), 9(1), pp. 157–162. doi:10.35451/jfm.v9i1.3890.